chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Moderna COVID Vaccine EUA  Patient was 16 years old and received the Moderna vaccine, which is only approved in patients age 18 and up. The state was contacted about what to do. State informed the clinic that the Moderna vaccine is likely to be approved for pediatrics age 12 years and older soon, so it was okay to proceed to give the 2nd dose of the vaccine when the time comes. Reportedly, as of 4/9/21 the patient tested positive for COVID but there is no further information regarding his case.
This spontaneous report was received from a medical assistant, referring to a 13 years old female patient. Information about the patient's pertinent medical history, previous drug reactions, allergies and concomitant medications was not provided. The medical assistant reported that, on 28-AUG-2018, the patient was vaccinated with PNEUMOVAX 23 for prophylaxis (dose number, frequency, route of administration and anatomical location of vaccination were not provided; lot number R000692, expiration date 09-SEP-2019). No adverse effects were reported. Further information was not provided.
On 11/26/14 patient still complains of sore and stiff arm where she can barely move her arm to lift.
Death   5/15/2021 Causes of death listed on death certificate: 1) COVID 19 pneumonia  2) Acute respiratory failure with hypoxia  3) Pulmonary embolism  4) Paroxysmal atrial fibrillation  Other: obesity, hypertension
Pt received the vaccine and headed to the waiting area. After approximately 5 minutes he approached the drop-off window and told the technician that he was not feeling well. As he spoke he began to rock backwards and then corrected forward. As he fell forward he grabbed the counter and hit his head then proceeded to fall to the floor. Two technicians attended to the patient by placing a pillow under his head and propping his feet up on a chair. I had been giving a COVID test at the drive-thru window but once I was alerted to the situation I addressed the situation and called 911 for a medic to assess the patient since he had hit his head when he fainted. The 911 dispatcher told me to sit with the patient and to make sure he continued to lay and to not consume any beverages or food until the paramedics arrived. The paramedics assessed the patient's blood pressure and blood sugar and was found to be alert and in good health. He denied any head or neck pain and declined transport to the hospital. He called his sister for a ride home.
The day after injection: severe flu-like symptoms (high fever, body aches all over (former injury sites), headache. Symptoms subsided after 24 hrs. The following days featured muscle cramps all over my body, brought on by exercise. Calves cramped the most with the left calf being injured from cramps. Upper shoulders and neck muscles seized. 'Hot spots' on my torso. Skin very sensitive to touch on side and back. Sleeping a lot more than usual. Fatigue has lasted a week. A week later and muscles are feeling somewhat better. Skin still very sensitive. Still more tired than usual. Still avoiding exercise until muscles feel 100%.
On 1/9/09 the patient called the office to say that as of 1/7/09, her arm from the injection site to the elbow was red, warm, and swollen.
Pain developed distal to injection site, began within several hours of the injection. Got progressively worse, by Friday she could not move her arm enough, secondary to pain, to dress herself. Slight improvement but still with abduction and extension Lt deltoid.
Itchy rash, red bumps in and around injection site. Injection site soreness four days later. Hard callously feeling around injection site on left arm where vaccine was given.
pt exp a unilateral sensori-neural hearing loss approx 2wk p/vax;the only link the MD noted is the temporal relationship;
Terrible pain in left arm, could not move arm for 3 days. Pain pills and heating pad, day and night. Then pain moved over to right for 3 days. Pain pills and heating pad. Did not go to doctor as I did not think they could do any better. If I was still working I would have lost a week of work.
This initial spontaneous case was received from other non-healthcare professional on 16-Aug-2018, concerns a male patient of unspecified age. On 14-Oct-2017, the patient was administered influenza vaccine (dose, route of administration, anatomical location, batch number, manufacture, trade name and expiry date: not reported). On an unspecified date in Oct-2017, after vaccination, the patient experienced pain, which lasted for 2 days. The patient had recovered from the event. The reporter assessed the case as non-serious. This case was linked to case number 201803259 due to same reporter.
Seen 02/13/2003 with soreness at injection site X 3 days. Fever, chills, nausea and decreased appetite X 2 days. With generalized abdominal pain X 2 days and numbness whole both arms X 3-4 days.
1215-Noted pt sitting on the floor fanning herself after receiving her COVID vaccine.  1220-Pt ambulates to stretcher for further evaulation of clinic staff, FNP.  Patient reported no previous adverse reaction to vaccines, but did note an anaphylactic nut allergy.  Pt reported a milder version of the symptoms she is experiencing today after her initial vaccine Dec 17, 2020. Initial HR 64 SPO2 74% room air(employee wearing dark fingernail polish and reporting tingling in her hands)  Pt instructed to breath slowly in through nose, out through mouth.  1225 BP 150/95 HR 85 SPO2 99% Pt given some water and crackers and reports eating NO food today other than a few cookies.  Pt reports feeling better, color has now returned to pt.  1235- BP systolic 180s. pt advised to be seen in the ED for further evaluation.  1240 patient taken to ED by this RN; FNP; and second RN for further evaluation. 2L SPO2 put on pt en route based on previous low oxygenation. 1245- Pt arrived in ED, pt began reporting blurred vision; handoff to ED staff. Evaluated by ED staff, medicated with 1L NS bolus, 125mg IV Methylprednisone; 20mg IV Famotidine, 50mg IV Benadryl. 1640-employee reported to ED complete resolution of symptoms . Employee discharged from ED with prescription for an Epi-pen and prednisone.
Fever of 101.4 and chills, started about 12 hours after and lasted the night until I took ibuprofen in the early morning 3-4am. Symptoms resolved in 36-48 hours.
had a bad Moderna shot; This spontaneous case was reported by an attorney and describes the occurrence of IMMUNISATION REACTION (had a bad Moderna shot) in a  patient of an unknown age and gender who received mRNA-1273 (Spikevax) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced IMMUNISATION REACTION (had a bad Moderna shot). At the time of the report, IMMUNISATION REACTION (had a bad Moderna shot) outcome was unknown.    The action taken with mRNA-1273 (Spikevax) (Unknown) was unknown.       No concomitant medication information provided.  No treatment medication information provided.
Patient complained of inflamed and hot left arm at site of injection.  Patient did not specify when the onset of these symptoms occured, but he required medical treatment from an urgent care facility 3 days after the vaccine was administered.
This is a spontaneous report received from a contactable consumer or other non-healthcare professional. An 82-years-old female patient received second dose of BNT162B2 (COVID-19 mRNA VACCINE, Formulation: Solution for injection, batch/lot number: not reported) via an unspecified route of administration on 04May2021 as single for COVID-19 immunisation. The patient received first dose of bnt162b2 (BNT162B2) on 04Apr2021. The patient medical history and concomitant medications were not reported. A week after administration of second dose of vaccination, the patient had a measles-like condition on her skin, all over the body. It was described as not like a rash but more like measles, it started small and spreading like measles or a chickenpox where in it looked like blood patches and it has been getting worse and bigger and itching from inside out and has been eating her up. She has already consulted her general doctor and dermatologist and had 3 biopsy to see what else they can do. The dermatologist said that they had a report filed on this but no reference number and that the caller should also report. The caller also added that she felt bad because she was the one who had her mother get vaccinated, where in she could have just stayed in the house and not catch the disease. Caller is asking for any advise on how to improve her mother's condition since it has been getting worse by the day. Information on the lot/batch number has been requested.
Hot to touch; Extremely red; Large knots; Both arms broke out in hives; Swelling in both arms; My arms itched; Right and left arms developed a rash; Fever in both arms; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of FEELING HOT (Hot to touch), ERYTHEMA (Extremely red), NODULE (Large knots), URTICARIA (Both arms broke out in hives) and PERIPHERAL SWELLING (Swelling in both arms) in a 90-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Allergy to chemicals (Sulfur). Concomitant products included NAPROXEN SODIUM (ALEVE) for an unknown indication.   On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced FEELING HOT (Hot to touch), ERYTHEMA (Extremely red), NODULE (Large knots), URTICARIA (Both arms broke out in hives), PERIPHERAL SWELLING (Swelling in both arms), PRURITUS (My arms itched), RASH (Right and left arms developed a rash) and PYREXIA (Fever in both arms). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Itch, at an unspecified dose and frequency and CORTISONE for Rash, at an unspecified dose and frequency. At the time of the report, FEELING HOT (Hot to touch), ERYTHEMA (Extremely red), URTICARIA (Both arms broke out in hives), PERIPHERAL SWELLING (Swelling in both arms) and PYREXIA (Fever in both arms) had resolved and NODULE (Large knots), PRURITUS (My arms itched) and RASH (Right and left arms developed a rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The patient was instructed to put cold and hot on her arm along with treatment with Benadryl.   Most recent FOLLOW-UP information incorporated above includes: On 11-Jun-2021: Significant follow up added, more events added
Loss of central vision in left eye.  Received tests and treatment (eye drops) from ophthalmologist, at Eye doctor.  Was referred to neuro ophthalmologist.  Numerous tests and follow up tests. Added 2 new eye drops.  Three different eye drops instilled in both eyes a total of 6 times/day.  At present, visual fields are stable but not showing improvement.
Itchy rash on chest, groin, buttocks, arms treated with Benadryl and hydrocortisone cream with improvement.
gotten the flu; Initial information received on 24-Oct-2020 regarding an unsolicited valid non-serious case received from a consumer or non-healthcare professional via social media.  This case involves a patient (unknown demographics) who got flu (influenza), when received INFLUENZA VACCINE.  The patient's past vaccination included Influenza vaccine for prophylactic vaccination with reaction of flu (influenza) (got the flu shot every year and have gotten the flu twice in the last five years).  The patient's medical history, past medical treatment, concomitant medication and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE (produced by unknown manufacturer, batch number not reported) via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient got the flu (influenza) (unknown latency) following the administration of INFLUENZA VACCINE.  Laboratory details were not reported.   It was not reported if the patient received a corrective treatment.  The event outcome was unknown for flu.  There will be no information available on the batch number for this case.
patient got a mild rash on both arms and hands after getting the covid booster and flu shot. they were ok and did not complain but wanted to bring it to our attention. the rash developed less than 24hr after the shots. patient was advised to take an antihistamine and to seek md if the rash gets worse or doesnt go away  patient states they developed a rash on their hands and arms less than 24 hours after the pfizer booster, patient also got the flu shot with the booster - patient states they did not get a rash on the first or second doses
10/4/16-Right leg pain after immunization. 10/3/16-minimal erythema, fever.
Apathetic; Fatigued; Tired; Exhausted; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0164), via an unspecified route of administration in the left arm on 19Apr2021 at 11:30 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient did not receive any other medication within two weeks of the COVID-19 vaccination. The patient previously received amoxicillin (MANUFACTURER UNKNOWN) and CECLOR from unknown dates for unknown indications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the left arm on 29Mar2021 at 11:30 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 19Apr2021 at 13:00, the patient felt tired, fatigued, exhausted and apathetic. On 28Apr2021, the patient underwent a nasal swab test (SARS-CoV-2 test) and tested negative. The clinical outcome of the events felt tired, fatigued, exhausted and apathetic was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
05/13/04- the parent noted reddened upper left deltoid- reddened & warm to touch, swollen, hardened approx. size 4" x 5". 05/14/04 area a little less red, less hard. Child using arm. No complaints of pain.
Patient came to our pharmacy on 8/19/21 at 4:15pm. He filled out our required VAR, where he reported that he had not received any previous Covid vaccine. Since he reported this, we did not check the Registry System. We gave him a new completed Vaccination Record Card and gave him his Moderna vaccine. After giving the vaccine, I told the patient he needed to wait the required 15 minutes in the waiting area. I then went to put his information into Registry System, and noticed that he received a Pfizer vaccine on 3/22/21 at pharmacy. I then asked the patient about this, asked him if he did get a vaccine there on that date and he told me that he did not get that vaccine there on that date. He stated that "if I did, I couldn't remember." The patient then asked if he should get the second Moderna vaccine. We told him that we would have to report this incident in VAERS, and call Pfizer to see what the required action should be. We verified his phone number and told him that we would give him a call once we had an answer; he verbalized understanding and thanked us before leaving. Seeing the previous Pfizer dose, and that the patient's address, we wanted to investigate further. We had our medical staff nurses check the Immunization Registry and found that patient received another Pfizer vaccine on 3/22/21 (the same day he received the Pfizer vaccine) and he also received a third Pfizer vaccine on 4/13/21. So the Moderna vaccine he received from us was his 4th total Covid vaccine.
From telephone contact received on 11/29/01, it was reported that an employee developed a red papular rash the same day she received a vaccination of Fluzone. Patient not evaluated by a physician. Self medicated with Benadryl 25 mg as directed Rash resolved in 24 hours.
dizziness and fatigue 5 hours after immunization received.  Swelling, soreness and redness at site. Lasted for four days.  2nd day - facial swelling occurred as well.  Ibuprofen and Benadryl taken regularly for 5 days.
Reaction 20 minutes post receiving vaccine. Check out "hives- breaking out on face, neck, chest, arms, nausea, weakness, lightheadedness."Self medicated with Tylenol and Benadryl. Did not report allergy to eggs. But states eggs made her sick when she was child 10/24/01. A follow up report received 11/1/2001 adds: Pt had long standing food sensitivity to eggs, hives still present 2 days after vaccination given. Pt's reaction has continued to subside, had no other vaccinations at that date or in the month prior. On no meds, no hx of previous AE's with vaccines. Has been advised not to take flu shot again.
anaphylaxis; head was feeling funny; sweating profusely; This is a spontaneous report from a contactable consumer (patient). This 79 (unit unknown) female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiry date: unknown) via an unspecified route of administration, on 10Feb2021 at 12:00, at a single dose, for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient received first dose on 10Feb2021 at 12:00. On the same day (10Feb2021), at 20:00, the patient's head was feeling funny, sweating profusely, and felt like "anaphylaxis". Patient also asked about potential receipt of second dose. Patient stated she will reach out to healthcare professional (HCP). Outcome of the events was unknown.  Information on the batch/lot number has been requested.
Patient received a dose of the Pfizer COVID-19 vaccine on 01/18/2021, however the patient received the second dose of the vaccine with the Moderna vaccine instead of the Pfizer as she was supposed to have received.
Drug dose administration interval too short; Intense burning sensation in all extremities (both hands and feet); Tingling; Described the pain as 'internal burning and felt like muscles were on fire'; This case was reported by a pharmacist via sales rep and described the occurrence of burning sensation in a 53-year-old female patient who received Herpes zoster (Shingrix) (batch number KJ9N5, expiry date 17th October 2021) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis, Flu Seasonal QIV Dresden (Fluarix Quadrivalent 2019-2020 season) for prophylaxis and cyanocobalamin (Vitamin B12 Injection) solution for injection for an unknown indication.   The patient's past medical history included pain, numbness and mixed sensory & motor neuropathy (in both feet). Previously administered products included Gabapentin (couldn't tolerate it) and Norco. Concurrent medical conditions included diabetes.   On 11th September 2019, the patient received the 1st dose of Shingrix (intramuscular) .5 ml. On 13th October 2019, the patient received the 2nd dose of Shingrix. On 11th September 2019, the patient received Fluarix Quadrivalent 2019-2020 season. On an unknown date, the patient started Vitamin B12 Injection at an unknown dose and frequency. On an unknown date, less than 3 months after receiving Shingrix, Fluarix Quadrivalent 2019-2020 season and Vitamin B12 Injection and not applicable after receiving Shingrix, the patient experienced burning sensation, tingling, pain and drug dose administration interval too short. The patient was treated with hydrocodone bitartrate + paracetamol (Norco). On an unknown date, the outcome of the burning sensation, tingling and pain were recovered/resolved and the outcome of the drug dose administration interval too short was unknown.   It was unknown if the reporter considered the burning sensation, tingling and pain to be related to Shingrix, Fluarix Quadrivalent 2019-2020 season and Vitamin B12 Injection.  Additional details were provided as follows: The health care professional asked whether there had been any report of patient getting a mild version of shingles after receiving Shingrix. The patient received Fluarix in the left deltoid and Vitamin B 12 injection in the right deltoid. The patient reported tingling, intense internal burning sensation in all extremities(both hands and feet) and felt like her muscle were on fire. The patient thought that was due to the Shingrix and rated the pain as a 9/10 which lasted for 1 and a half day. On 3rd October 2019, the patient thought she should get 2nd dose of Shingrix. The patient had Norco at home and took some. The patient said that the pain lasted 1 and a half days and described the pain as internal burning and felt like her muscles were on fire. On 13th October 2019, the patient received 2nd dose of Shingrix which was earlier than the recommended schedule, which led to drug dose interval too short. The Health care professional assumed everything was alright. The reporter agreed to follow-up by GlaxoSmithKline.
Headache, Myalgia, Arthralgia, Fever, HYPERglycemia,  injection site soreness
I developed symptoms of Bells Palsy within a week of receiving the first Moderna vaccine with full-blown Bells Palsy on 9/11/21
Scratchy throat and wheezing, body ache and fatigue. Was in bed all weekend. Feeling 90% better. Still experiences some dyspnea but does not feel she needs to see MD.
Information has been received from a physician assistant concerning a 16 year old female patient who was vaccinated with the first dose of GARDASIL on an unspecified date. Subsequently the patient experienced pain, headache and fever. The patient went ahead and received the second dose of GARADSIL (IM, 0.5 ml) and experienced fever. The patient declined receiving the third dose. At the reporting time the outcome was unknown. Additional information has been requested.
Information has been received from a pharmacist and a registered nurse concerning a patient of unknown age and gender. The patient's medical history, concurrent condition and concomitant therapy were not reported. On 31-JUL-2015 (today), the patient was vaccinated with an expired dose of VARIVAX (Merck) lot# reported as K006960, expiration date 24-JUL-2015 (dose and route not reported). No adverse effects were reported. Additional information has been requested.
On Monday November 15th patient experienced onset of pruritus around 6:00 p.m..  The following day Tuesday 11/16/2021 she developed welts on her chest which progressed to most of the skin surfaces over the course of 1-2 days.  She also experienced joint pain and swelling in the wrists, finger joints, then also knees and ankles.  The joints  swelling was prominent in her wrists and hands such that she had removed her  ring on her finger.  She had to remove her watch.  She could not close her hands for 3-4 days.  The joint swelling resolved after around 1 week before she could go back to exercise.  She has had persisting  dermatographia some at least into January 27, 2022.  She has a dermatitis type rash on the upper chest and upper back.    Estimated 9 month due date is June 3, 2022. (  Estimated 9 weeks pregnant at time of vaccine and around 10-11 weeks pregnant at the time of the onset of the pruritus and then rash and joint swelling) She appears to have had an otherwise normal pregnancy and describes very strict avoidance of any gluten products with a known history of celiac disease.
Approximately one week after Pfizer Covid vaccine, experienced around 4 cm diameter area with redness, mild tenderness, and itchiness at injection site on left deltoid.